UPDATE 1-FDA staff says Amgen biosimilar 'highly similar' to Abbvie's Humira - Reuters

Reuters

UPDATE 1-FDA staff says Amgen biosimilar 'highly similar' to Abbvie's Humira Reuters (Adds details on FDA staff findings). July 8 Amgen Inc's biosimilar form of AbbVie Inc's Humira arthritis drug, the world's top-selling medicine, is similarly potent and safe as the original product, according to a preliminary review by staff members ... FDA staff says Amgen biosimilar 'highly similar' to Abbvie's HumiraYahoo Finance all 3 news articles »

from Health - Google News http://news.google.com/news/url?sa=t&fd=R&ct2=us&usg=AFQjCNEYoERmj7PQFW-o-I29eYFgAxvlVA&clid=c3a7d30bb8a4878e06b80cf16b898331&cid=52779152874208&ei=SKp_V-iqHtS_3gG596-wCw&url=http://www.reuters.com/article/amgen-humira-biosimilar-idUSL1N19U0J3
via IFTTT